Nyxoah Reports Third Quarter 2022 Financial and Operating Results
Mont-Saint-Guibert, Belgium, Nov. 8 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the quarter ended September 30, 2022. Third Quarter 2022 Financial and Operating Highlights Completed 110 of 115 implants in the DREAM U.S. [...]







